CBOE (CBOE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

01.08.25 15:30 Uhr

Werte in diesem Artikel
Aktien

195,75 EUR -1,40 EUR -0,71%

67,50 EUR -1,50 EUR -2,17%

Indizes

6.606,8 PKT -8,5 PKT -0,13%

CBOE Global (CBOE) reported $587.3 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 14.3%. EPS of $2.46 for the same period compares to $2.15 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $572.24 million, representing a surprise of +2.63%. The company delivered an EPS surprise of +1.65%, with the consensus EPS estimate being $2.42.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how CBOE performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Average Revenue Per Contract by Product - Options - Index options: $0.92 compared to the $0.91 average estimate based on seven analysts.Average Daily Volume by Product - Options - Multi-listed options: 12.62 million compared to the 12.58 million average estimate based on seven analysts.Average Revenue Per Contract by Product - Futures: $1.67 versus $1.73 estimated by seven analysts on average.Average Daily Volume by Product - Options - Index options: 4.69 million versus 4.62 million estimated by seven analysts on average.Revenues- Market data fees- Total: $82.4 million compared to the $78.9 million average estimate based on seven analysts.Revenues- Access and capacity fees- Total: $101.2 million versus the seven-analyst average estimate of $98.73 million.Revenues- Net transaction and clearing fees: $429 million versus the five-analyst average estimate of $423.8 million. The reported number represents a year-over-year change of +14.7%.Revenues- Other revenue- Total: $25.4 million versus $28.18 million estimated by four analysts on average.Revenues- Futures- Transaction and clearing fees: $24.3 million versus the three-analyst average estimate of $28.59 million. The reported number represents a year-over-year change of -13.5%.Revenues- Regulatory fees- Total: $96.8 million versus $135.21 million estimated by three analysts on average.Revenues- Transaction and clearing fees- Total: $867.7 million compared to the $789.44 million average estimate based on three analysts.Revenues- Net transaction and clearing fees- Global FX: $20.4 million compared to the $19.73 million average estimate based on three analysts.View all Key Company Metrics for CBOE here>>>Shares of CBOE have returned +4.2% over the past month versus the Zacks S&P 500 composite's +2.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cboe Global Markets, Inc. (CBOE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: CBOE und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CBOE

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CBOE

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu CBOE Holdings Inc

Wer­bung

Analysen zu CBOE Holdings Inc

DatumRatingAnalyst
10.07.2018CBOE BuyCompass Point
13.02.2018CBOE BuyDeutsche Bank AG
16.10.2017CBOE Sector PerformRBC Capital Markets
08.09.2017CBOE Equal WeightBarclays Capital
31.03.2017CBOE OutperformRBC Capital Markets
DatumRatingAnalyst
10.07.2018CBOE BuyCompass Point
13.02.2018CBOE BuyDeutsche Bank AG
31.03.2017CBOE OutperformRBC Capital Markets
02.05.2016CBOE OutperformRBC Capital Markets
09.12.2015CBOE OutperformRBC Capital Markets
DatumRatingAnalyst
16.10.2017CBOE Sector PerformRBC Capital Markets
08.09.2017CBOE Equal WeightBarclays Capital
27.09.2016CBOE Sector PerformRBC Capital Markets
08.01.2016CBOE HoldDeutsche Bank AG
06.01.2016CBOE NeutralUBS AG
DatumRatingAnalyst
02.05.2016CBOE UnderweightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CBOE Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen